Viewing Study NCT06056895


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2025-12-27 @ 9:27 PM
Study NCT ID: NCT06056895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-16
First Post: 2023-09-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
Sponsor: University of Washington
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module